Clouds are a good thing.
Cloud and SaaS computing now make it possible to connect people, information, and collaboration capabilities anywhere — instantly. Sounds easy, but it’s hard to make simple. Some of our portfolio companies make it amazing. Learn more »
Plug in. Turn on.
New smart grid communications solutions gives utilities the technology they need to enhance energy efficiency, lower operating costs and integrate renewable energy sources. Learn more »
Intercepting Enemy Signals.
Understanding cell signaling pathways may make it possible to intercept, interpret, and disrupt cancer cell signals. That’s just one of many innovative ways that our portfolio companies are attacking complex diseases. Learn more »
Significant innovation requires some backbone.
Patients with back pain can thank innovative spinal surgeons for minimally invasive fusion technologies. Relieving pain, shortening hospital stays, and improving outcomes. We’re all about that. Learn More »
Financing the Growth of Tomorrow’s Companies Today
To see the future, meet our companies. We invest in venture-backed companies that are changing the world through technology, energy technology, and life science innovation. Learn More »
Hercules, a NYSE listed specialty finance company, is focused on financing the growth of tomorrow’s most innovative companies today. We provide senior secured loans and select equity financing solutions to entrepreneurial companies in the technology, energy technology and life science and healthcare sectors to help them reach critical growth milestones at all stages of development.
With commitments of approximately $3.9 billion to more than 250 companies since its first origination in October 2004, Hercules is recognized as a lender of choice for top entrepreneurs as well as venture capital and private equity firms seeking growth capital financing solutions for portfolio companies.
11/07/2013Hercules Technology Growth Capital Announces Third Quarter 2013 Financial Results and Raises Quarterly Cash Dividend to $0.31 per Share, up $0.03 From Second Quarter 2013, an Increase of Approximately 11.00%